The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001).
 
Hitoshi Katai
Honoraria - Johnson & Johnson
 
Yuichiro Doki
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; MSD; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Yukinori Kurokawa
Honoraria - Daiichi Sankyo; Johnson & Johnson; Medtronic; MSD; Olympus; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology
Research Funding - Lilly
 
Yutaka Kimura
No Relationships to Disclose
 
Shuji Takiguchi
No Relationships to Disclose
 
Yasunori Nishida
No Relationships to Disclose
 
Takeshi Sano
Speakers' Bureau - Johnson & Johnson; Medtronic; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kenichi Nakamura
Honoraria - Bayer Yakuhin; Chugai Pharma
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb Japan (Inst); Chugai/Roche (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyorin (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Mitsuru Sasako
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Lilly Japan; Merck; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Olympus
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)